Changes of Serum Angiotensin Peptides, Pro-Endothelin-1 Levels in Women One Year After Preeclampsia and their Association with Cardiovascular Risk Factors
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Uzan J, Carbonnel M, Piconne O, et al. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011; 7: 467–474.Search in Google Scholar
Eiland E, Nzerue C, Faulkner M. Preeclampsia. J Pregnancy. Jul 11 2012; 586578.Search in Google Scholar
ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019 Jan;133(1):1.Search in Google Scholar
Prakash J, Ganiger VC. Acute Kidney Injury in Pregnancy-specific Disorders. Indian J Nephrol. 2017; 27(4):258-70.Search in Google Scholar
Stanhewicz AE. Residual vascular dysfunction in women with a history of preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2018 Dec 1;315(6):R1062-R1071.Search in Google Scholar
Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387:999–1011.Search in Google Scholar
Mohseni Z, Derksen E, Oben J, et al. Cardiac dysfunction after preeclampsia; an overview of pro- and anti-fibrotic circulating effector molecules. Pregnancy Hypertens. 2021 Mar;23:140-154.Search in Google Scholar
Smith GN, Walker MC, Liu A, et al. Pre-Eclampsia New Emerging Team (PE-NET). A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol. 2009 Jan;200(1):58.e1-8.Search in Google Scholar
Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.Search in Google Scholar
Benschop L, Duvekot JJ, Versmissen J, et al, Roeters van Lennep JE. Blood Pressure Profile 1 Year After Severe Preeclampsia. Hypertension. 2018 Mar;71(3):491-498.Search in Google Scholar
Kuenzli A, Bucher HC, Anand I. et al. Metaanalysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure. PLoS One 2010, 5: e9946.Search in Google Scholar
Heusch G, Libby P, Gersh B. Cardiovascular remodeling in coronary artery disease and heart failure. Lancet. 2014, 383: 1933-1943.Search in Google Scholar
Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007; 292: 82–97.Search in Google Scholar
Hladunewich MA, Kingdom J, Odutayo A, K. Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia, J. Clin. Endocrinol. Metab. 2011;96(11): 3517–3524.Search in Google Scholar
Seely EW, Rich-Edwards J, Lui J, et al. Risk of future cardiovascular disease in women with prior preeclampsia: a focus group study. BMC Pregnancy Childbirth. 2013 Dec 21;13:240.Search in Google Scholar
Zhang L, Tian J, Zhou Y, et al. Angiotensin-(1-7) attenuates damage to podocytes induced by preeclamptic serum through MAPK pathways. Int J Mol Med. 2014 Oct;34(4):1057-64.Search in Google Scholar
Spaan J, Brown M. Renin-angiotensin system in pre-eclampsia: everything old is new again. Obstet Med. 2012 Dec;5(4):147-153Search in Google Scholar
De Lima ASD, Holanda IP, Nascimento PRP, et al. Plasma angiotensin II levels in women with severe preeclampsia under magnesium sulphate regimen. Pregnancy Hypertens. 2021; 23: 56-58.Search in Google Scholar
Leaños-Miranda A, Campos-Galicia I, Ramírez-Valenzuela KL, et al. Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia. Hypertension. 2013 May;61(5):1118-25.Search in Google Scholar
Van der Graaf AM, Toering TJ, Faas MM, Titia Lely A. From preeclampsia to renal disease: a role of angiogenic factors and the renin-angiotensin aldosterone system? Nephrol. Dial. Transplant. 2012; 27 (suppl 3) iii51–iii57.Search in Google Scholar
Stanhewicz AE, Jandu S, Santhanam L, Alexander LM. Increased angiotensin II sensitivity contributes to microvascular dysfunction in women who have had preeclampsia. Hypertension. 2017; 70(2):382-389.Search in Google Scholar
Kim SY, Ryu HM, Yang JH, et al. Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia. J Korean Med Sci. 2004 Oct;19(5):688-92.Search in Google Scholar
Verhaar MC, Rabelink TJ. The endothelium: a gynecological and obstetric point of view. Eur J Obst Gyn Reprod Biol 2001; 94: 180-5.Search in Google Scholar
Roberts JM, Taylor RN, Musci TJ, et al.. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161; 1200-4.Search in Google Scholar
Krauss T, et al. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obst Gynecol 1997; 177: 443-9.Search in Google Scholar
Sibai BM. Risk factors, pregnancy complications, and prevention of hypertensive disorders in women with pregravid diabetes mellitus. J Matern-Fetal Med 2000; 9: 62-5.Search in Google Scholar
Sugi T, Makino T. Autoantibodies to contact proteins in patients with recurrent pregnancy losses. J Reprod Immunol 2002; 53: 269-77.Search in Google Scholar
Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999; 353: 1348-53.Search in Google Scholar
Christ-Crain M, Morgenthaler NG, et al. Mid-regional proadrenomedullin as a prognostic marker in sepsis: An observational study. Critical Care. 2005; 9(6): R816–R824.Search in Google Scholar
Tuzcu ZB, Asicioglu E, Sunbul M, et al. Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women. Am J Obstet Gynecol. 2015 Oct;213(4):533.e1-7.Search in Google Scholar
Vickers M, Ford I, Morrison R, et al. Markers of endothelial activation and atherothrombosis in women with history of preeclampsia or gestational hypertension. Thromb Haemost. 2003 Dec;90(6):1192-7.Search in Google Scholar
European Society of Cardiology (ESC) Guideline for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39(34): 3165–3241.Search in Google Scholar
Behrens I, Basit S, Melbye M, et al. Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. BMJ. 2017;358:j3078.Search in Google Scholar
Breetveld NM, Ghossein-Doha C, Van Kuijk S, et al. Cardiovascular disease risk is only elevated in hypertensive, formerly preeclamptic women. BJOG. 2015;122:1092–1100.Search in Google Scholar
Bushnell C, Chireau M. Preeclampsia and stroke: risks during and after pregnancy. Stroke Res Treat. 2011;2011:858134.Search in Google Scholar
Wenger NK. Recognizing pregnancy-associated cardiovascular risk factors. Am J Cardiol. 2014;113(2):406-409.Search in Google Scholar
Heidema WM, Scholten RR, Lotgering FK, et al. History of preeclampsia is more predictive of cardiometabolic and cardiovascular risk factors than obesity. Eur J Obstet Gynecol Reprod Biol. 2015;194:189-193.Search in Google Scholar
Bokslag A, Teunissen PW, Franssen C, et al. Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life. Am J Obstet Gynecol. 2017;216:523.e1–523.e7.Search in Google Scholar
Mendoza-Torres E, Oyarzún A, Mondaca-Ruff D, et al. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension. Ther Adv Cardiovasc Dis. 2015 Aug;9(4):217-37.Search in Google Scholar
Wallukat G, Homuth V, Fischer T. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999; 103(7): 945–952.Search in Google Scholar
Siddiqui AH, Irani RA, Blackwell SC. Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension 2010; 55(2): 386–393.Search in Google Scholar
Irani RA, Xia Y. Renin angiotensin signaling in normal pregnancy and preeclampsia. Semin Nephrol. 2011; 31:47–58.Search in Google Scholar
Irani RA, Xia Y. The functional role of the renin–angiotensin system in pregnancy and preeclampsia. Placenta 2008;29(9): 763–771.Search in Google Scholar
Shah DM. Role of the renin-angiotensin system in the pathogenesis of preeclampsia, Am J Physiol-Renal Physiol 2005; 288 (4): F614–F625.Search in Google Scholar
Rodriguez M, Moreno J, Hasbun J. RAS in pregnancy and preeclampsia and eclampsia, Int J Hypertension. 2012:1–6.Search in Google Scholar
Van der Graaf AM, Toering TJ, Faas MM, Titia Lely A. From preeclampsia to renal disease: a role of angiogenic factors and the renin-angiotensin aldosterone system? Nephrol Dial Transplant. 2012; 27 (suppl 3): iii51–iii57.Search in Google Scholar
Hladunewich MA, Kingdom J, Odutayo A, et al. Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia, J Clin Endocrinol Metab. 2011; 96(11): 3517–3524.Search in Google Scholar
Saxena AR, Seely EW, Goldfine AB. Cardiovascular risk factors and menstrual cycle phase in pre-menopausal women. J Endocrinol Invest. 2012 Sep;35(8):715-9.Search in Google Scholar
Saxena AR, Karumanchi SA, Brown NJ, et al. Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension. 2010; 55:1239–1245.Search in Google Scholar
Zhang L, Zhou Y, Wu Q, et al. Effective prediction of preeclampsia by measuring serum angiotensin II, urinary angiotensinogen and urinary transforming growth factor β1. Exp Ther Med. 2017 Jul;14(1):391-397.Search in Google Scholar
Chase V, McBride C, Badger G, et al. Association of pre-pregnancy and longitudinal change in angiotensin-II with preterm preeclampsia. 2017, Poster session V| 216(1), Suppl., S530.Search in Google Scholar
Merrill DC, Karoly M, Chen K, et al. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine. 2002 Aug;18(3):239-45.Search in Google Scholar
Brosnihan KB, Merrill DC, Yamaleyeva LM, et al. Longitudinal study of angiotensin peptides in normal and pre-eclamptic pregnancy. Endocrine. 2020 Aug;69(2):410-419.Search in Google Scholar
Leanos-Miranda A, Inova Campos-Galicia, Mendez-Aguilar F. Lower circulating angiotensin II levels are related to the severity of preeclampsia and its risk as disclosed by a specific bioassay. Medicine (Baltimore). 2018; 97(39): e12498.Search in Google Scholar
Baev O, Khlestova G, Romanov A. Changes of angiotensin II and angiotensin (1-7) levels in early and late-onset preeclampsia. Abstracts of European Journal of Obstetrics and Gynecology and Reproductive Biology. March 01, 2019 Session 10 – Obstetrics: Hypertension reference: a2286OB, Vol. 234, e26.Search in Google Scholar
Khlestova GV, Romanov AY, Nizyaeva NV, et al. Dynamics of Renin, Angiotensin II, and Angiotensin (1-7) during Pregnancy and Predisposition to Hypertension-Associated Complications. Bull Exp Biol Med. 2018 Aug;165(4):438-439.Search in Google Scholar
Velloso EP, Vieira R, Cabral AC, et al. Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I-converting enzyme deletion/deletion genotype. Braz J Med Biol Res. 2007 Apr;40(4):583-90.Search in Google Scholar
Davenport AP, Hyndman KA, Dhaun N, et al. Endothelin. Pharmacol Rev. 2016 Apr;68(2):357-418.Search in Google Scholar
Unic A, Derek L, Hodak N, et al. Endothelins – clinical perspectives. Biochem Med (Zagreb). 2011;21(3):231-42.Search in Google Scholar
Tschaikowsky K, Sägner S, Lehnert N, et al. Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines. Crit Care Med. 2000 Jun;28(6):1854-60.Search in Google Scholar
Eto M, Barandiér C, Rathgeb L, et al. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ Res. 2001 Sep 28;89(7):583-90.Search in Google Scholar
Adlbrecht C, Hulsmann M, Strunk G, et al. Prognostic value of plasma midregional pro-adrenomedullin and c-terminal-pro-endothelin-1 in chronic heart failure outpatients. Eur J Heart Fail 2009;11:361-6.Search in Google Scholar
Neuhold S, Huelsmann M, Strunk G, et al. Comparison of copeptin, b-type natriuretic peptide, and amino-terminal prob-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. J Am Coll Cardiol. 2008;52:266-72.Search in Google Scholar
Habib A, Al-Omari MA, Khaleghi M, et al. Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertension. Am J Hypertens. 2010 Nov;23(11):1204-8.Search in Google Scholar
Al-Omari MA, Khaleghi M, Mosley TH Jr, et al. Plasma Cterminal pro-endothelin-1 is associated with left ventricular mass index and aortic root diameter in African-American adults with hypertension. J Hum Hypertens. 2011 Feb;25(2):106-13.Search in Google Scholar
Haryono A, Ramadhiani R, Ryanto GRT, Emoto N. Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going. Biology (Basel). 2022 May 16;11(5):759.Search in Google Scholar
Wellman S, Benzing J, Fleischlin S. Cardiovascular Biomarkers in Preeclampsia at Triage. Fetal Diagn Ther. 2014; 36:202–207.Search in Google Scholar
Malte AL, Uldbjerg N, Wright D, Torring N. Prediction of severe pre-eclampsia/HELLP syndrome by combination of sFlt1, CT-pro-ET-1, and blood pressure: exploratory study. Ultrasound Obstet Gymecol. 2018; 51: 768-774.Search in Google Scholar
